{"entity":{"type":"insider","cik":"0001376960","url":"/insider/0001376960","json_url":"/insider/0001376960.json","name":"Aryeh Jason","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":204,"n_filings":95,"first":"2007-06-01","last":"2026-06-12","span_basis":"filed_date"},"name_variants":[{"name":"Aryeh Jason","source":"filing","n_filings":95,"first_seen":"2007-06-01","last_seen":"2026-06-12"}],"transactions":[{"id":5820156,"accession":"0002001011-26-000103","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002001011-26-000103","line_url":"/filing/0002001011-26-000103#line-3","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":250.0,"price_display":"250.00","price_state":"stated","total_value":1125000.0,"total_display":"1,125,000.00","total_whole":"1,125,000","shares_owned_after":102580.0,"shares_owned_after_display":"102,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-11","filed_date":"2026-06-12","scope":"insider"},{"id":5820155,"accession":"0002001011-26-000103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002001011-26-000103","line_url":"/filing/0002001011-26-000103#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":250.0,"price_display":"250.00","price_state":"stated","total_value":125000.0,"total_display":"125,000.00","total_whole":"125,000","shares_owned_after":107080.0,"shares_owned_after_display":"107,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-10","filed_date":"2026-06-12","scope":"insider"},{"id":6034701,"accession":"0001104659-26-064136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-064136","line_url":"/filing/0001104659-26-064136#line-1","is_derivative":false,"issuer_cik":"0001376960","issuer_name":"Orchestra BioMed Holdings, Inc.","issuer_ticker":"OBIO","issuer_name_source":null,"issuer_url":"/issuer/0001376960","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":665.0,"shares_display":"665","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":2493.75,"total_display":"2,493.75","total_whole":"2,494","shares_owned_after":118118.0,"shares_owned_after_display":"118,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-20","scope":"insider"},{"id":6169053,"accession":"0001104659-26-063511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-063511","line_url":"/filing/0001104659-26-063511#line-1","is_derivative":false,"issuer_cik":"0001376960","issuer_name":"Orchestra BioMed Holdings, Inc.","issuer_ticker":"OBIO","issuer_name_source":null,"issuer_url":"/issuer/0001376960","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8971.0,"shares_display":"8,971","price_per_share":3.9,"price_display":"3.90","price_state":"stated","total_value":34986.9,"total_display":"34,986.90","total_whole":"34,987","shares_owned_after":117453.0,"shares_owned_after_display":"117,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-19","scope":"insider"},{"id":4858244,"accession":"0002001011-25-000082","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002001011-25-000082","line_url":"/filing/0002001011-25-000082","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":170.8087722,"price_display":"170.81","price_state":"stated","total_value":1708087.722,"total_display":"1,708,087.72","total_whole":"1,708,088","shares_owned_after":70243.0,"shares_owned_after_display":"70,243","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-23","filed_date":"2025-09-24","scope":"insider","n_lines":3},{"id":4267477,"accession":"0001104659-25-091775","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-091775","line_url":"/filing/0001104659-25-091775#line-1","is_derivative":false,"issuer_cik":"0001376960","issuer_name":"Orchestra BioMed Holdings, Inc.","issuer_ticker":"OBIO","issuer_name_source":null,"issuer_url":"/issuer/0001376960","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.45,"price_display":"2.45","price_state":"stated","total_value":2450.0,"total_display":"2,450.00","total_whole":"2,450","shares_owned_after":108482.0,"shares_owned_after_display":"108,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-19","filed_date":"2025-09-19","scope":"insider"},{"id":8305600,"accession":"0000886163-19-000163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-19-000163","line_url":"/filing/0000886163-19-000163#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750.0,"shares_display":"750","price_per_share":87.01,"price_display":"87.01","price_state":"stated","total_value":65257.5,"total_display":"65,257.50","total_whole":"65,258","shares_owned_after":67203.0,"shares_owned_after_display":"67,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-04","scope":"insider"},{"id":8305597,"accession":"0000886163-19-000145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-19-000145","line_url":"/filing/0000886163-19-000145#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":746.0,"shares_display":"746","price_per_share":90.008,"price_display":"90.01","price_state":"stated","total_value":67145.968,"total_display":"67,145.97","total_whole":"67,146","shares_owned_after":66453.0,"shares_owned_after_display":"66,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-05","filed_date":"2019-08-06","scope":"insider"},{"id":8085862,"accession":"0000886163-19-000132","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000886163-19-000132","line_url":"/filing/0000886163-19-000132#line-3","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":754.0,"shares_display":"754","price_per_share":92.9994,"price_display":"93.00","price_state":"stated","total_value":70121.5476,"total_display":"70,121.55","total_whole":"70,122","shares_owned_after":65707.0,"shares_owned_after_display":"65,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-31","filed_date":"2019-07-31","scope":"insider"},{"id":8085858,"accession":"0000886163-19-000132","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-19-000132","line_url":"/filing/0000886163-19-000132#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":100.2209,"price_display":"100.22","price_state":"stated","total_value":300662.7,"total_display":"300,662.70","total_whole":"300,663","shares_owned_after":64953.0,"shares_owned_after_display":"64,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-30","filed_date":"2019-07-31","scope":"insider"},{"id":8085854,"accession":"0000886163-19-000132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-19-000132","line_url":"/filing/0000886163-19-000132#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":106.01,"price_display":"106.01","price_state":"stated","total_value":26502.5,"total_display":"26,502.50","total_whole":"26,503","shares_owned_after":61953.0,"shares_owned_after_display":"61,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-29","filed_date":"2019-07-31","scope":"insider"},{"id":8762614,"accession":"0000921895-19-002020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-19-002020","line_url":"/filing/0000921895-19-002020#line-1","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":302.0,"shares_display":"302","price_per_share":5.44,"price_display":"5.44","price_state":"stated","total_value":1642.88,"total_display":"1,642.88","total_whole":"1,643","shares_owned_after":3802.0,"shares_owned_after_display":"3,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-16","filed_date":"2019-07-18","scope":"insider"},{"id":8235328,"accession":"0000921895-19-002005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000921895-19-002005","line_url":"/filing/0000921895-19-002005","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3400.0,"shares_display":"3,400","price_per_share":5.683529411764706,"price_display":"5.68","price_state":"stated","total_value":19324.0,"total_display":"19,324.00","total_whole":"19,324","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-12","filed_date":"2019-07-15","scope":"insider","n_lines":2},{"id":8235319,"accession":"0000921895-19-002005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-19-002005","line_url":"/filing/0000921895-19-002005#line-1","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.71,"price_display":"5.71","price_state":"stated","total_value":571.0,"total_display":"571.00","total_whole":"571","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-11","filed_date":"2019-07-15","scope":"insider"},{"id":8633131,"accession":"0000886163-19-000115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-19-000115","line_url":"/filing/0000886163-19-000115#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":107.01,"price_display":"107.01","price_state":"stated","total_value":26752.5,"total_display":"26,752.50","total_whole":"26,753","shares_owned_after":61703.0,"shares_owned_after_display":"61,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-11","filed_date":"2019-06-12","scope":"insider"},{"id":8223538,"accession":"0000886163-19-000090","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000886163-19-000090","line_url":"/filing/0000886163-19-000090#line-3","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":108.51,"price_display":"108.51","price_state":"stated","total_value":54255.0,"total_display":"54,255.00","total_whole":"54,255","shares_owned_after":60618.0,"shares_owned_after_display":"60,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2019-05-31","scope":"insider"},{"id":8223534,"accession":"0000886163-19-000090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-19-000090","line_url":"/filing/0000886163-19-000090#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":110.01,"price_display":"110.01","price_state":"stated","total_value":27502.5,"total_display":"27,502.50","total_whole":"27,503","shares_owned_after":60118.0,"shares_owned_after_display":"60,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-30","filed_date":"2019-05-31","scope":"insider"},{"id":8223527,"accession":"0000886163-19-000090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-19-000090","line_url":"/filing/0000886163-19-000090#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":111.01,"price_display":"111.01","price_state":"stated","total_value":27752.5,"total_display":"27,752.50","total_whole":"27,753","shares_owned_after":59868.0,"shares_owned_after_display":"59,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-29","filed_date":"2019-05-31","scope":"insider"},{"id":8085850,"accession":"0000886163-19-000085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-19-000085","line_url":"/filing/0000886163-19-000085#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":112.01,"price_display":"112.01","price_state":"stated","total_value":28002.5,"total_display":"28,002.50","total_whole":"28,003","shares_owned_after":59618.0,"shares_owned_after_display":"59,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-22","scope":"insider"},{"id":8757271,"accession":"0000886163-19-000083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-19-000083","line_url":"/filing/0000886163-19-000083#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":112.51,"price_display":"112.51","price_state":"stated","total_value":28127.5,"total_display":"28,127.50","total_whole":"28,128","shares_owned_after":59368.0,"shares_owned_after_display":"59,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-14","filed_date":"2019-05-16","scope":"insider"},{"id":7908541,"accession":"0000886163-19-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-19-000054","line_url":"/filing/0000886163-19-000054#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":202.0,"shares_display":"202","price_per_share":112.51,"price_display":"112.51","price_state":"stated","total_value":22727.02,"total_display":"22,727.02","total_whole":"22,727","shares_owned_after":51594.0,"shares_owned_after_display":"51,594","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-13","filed_date":"2019-03-15","scope":"insider"},{"id":6380634,"accession":"0000886163-18-000123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-18-000123","line_url":"/filing/0000886163-18-000123#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26862.0,"shares_display":"26,862","price_per_share":241.8122,"price_display":"241.81","price_state":"stated","total_value":6495559.3164,"total_display":"6,495,559.32","total_whole":"6,495,559","shares_owned_after":51392.0,"shares_owned_after_display":"51,392","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-17","filed_date":"2018-08-17","scope":"insider"},{"id":6380630,"accession":"0000886163-18-000123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-18-000123","line_url":"/filing/0000886163-18-000123#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1080.0,"shares_display":"1,080","price_per_share":245.0,"price_display":"245.00","price_state":"stated","total_value":264600.0,"total_display":"264,600.00","total_whole":"264,600","shares_owned_after":78254.0,"shares_owned_after_display":"78,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-16","filed_date":"2018-08-17","scope":"insider"},{"id":6592846,"accession":"0000886163-18-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-18-000046","line_url":"/filing/0000886163-18-000046#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":176.4747,"price_display":"176.47","price_state":"stated","total_value":705898.8,"total_display":"705,898.80","total_whole":"705,899","shares_owned_after":79334.0,"shares_owned_after_display":"79,334","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-09","filed_date":"2018-03-09","scope":"insider"},{"id":6592844,"accession":"0000886163-18-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-18-000046","line_url":"/filing/0000886163-18-000046#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":174.8843,"price_display":"174.88","price_state":"stated","total_value":612095.05,"total_display":"612,095.05","total_whole":"612,095","shares_owned_after":83334.0,"shares_owned_after_display":"83,334","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-08","filed_date":"2018-03-09","scope":"insider"},{"id":6536988,"accession":"0000886163-18-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-18-000028","line_url":"/filing/0000886163-18-000028#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3417.0,"shares_display":"3,417","price_per_share":155.0,"price_display":"155.00","price_state":"stated","total_value":529635.0,"total_display":"529,635.00","total_whole":"529,635","shares_owned_after":86834.0,"shares_owned_after_display":"86,834","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-23","filed_date":"2018-02-27","scope":"insider"},{"id":4522082,"accession":"0000886163-17-000144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-17-000144","line_url":"/filing/0000886163-17-000144#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24400.0,"shares_display":"24,400","price_per_share":140.22,"price_display":"140.22","price_state":"stated","total_value":3421368.0,"total_display":"3,421,368.00","total_whole":"3,421,368","shares_owned_after":90251.0,"shares_owned_after_display":"90,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-17","filed_date":"2017-11-20","scope":"insider"},{"id":4966816,"accession":"0000886163-17-000108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-17-000108","line_url":"/filing/0000886163-17-000108#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":127.99,"price_display":"127.99","price_state":"stated","total_value":255980.0,"total_display":"255,980.00","total_whole":"255,980","shares_owned_after":114651.0,"shares_owned_after_display":"114,651","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-08-23","filed_date":"2017-08-25","scope":"insider"},{"id":4302776,"accession":"0001104659-17-034708","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-17-034708","line_url":"/filing/0001104659-17-034708#line-3","is_derivative":false,"issuer_cik":"0001376960","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001376960","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104176.0,"shares_display":"104,176","price_per_share":1.4099,"price_display":"1.41","price_state":"stated","total_value":146877.7424,"total_display":"146,877.74","total_whole":"146,878","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-23","filed_date":"2017-05-24","scope":"insider"},{"id":4302767,"accession":"0001104659-17-034708","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-034708","line_url":"/filing/0001104659-17-034708#line-2","is_derivative":false,"issuer_cik":"0001376960","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001376960","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233468.0,"shares_display":"233,468","price_per_share":1.4236,"price_display":"1.42","price_state":"stated","total_value":332365.0448,"total_display":"332,365.04","total_whole":"332,365","shares_owned_after":104176.0,"shares_owned_after_display":"104,176","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-22","filed_date":"2017-05-24","scope":"insider"},{"id":4302763,"accession":"0001104659-17-034708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-034708","line_url":"/filing/0001104659-17-034708#line-1","is_derivative":false,"issuer_cik":"0001376960","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001376960","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51041.0,"shares_display":"51,041","price_per_share":1.5587,"price_display":"1.56","price_state":"stated","total_value":79557.6067,"total_display":"79,557.61","total_whole":"79,558","shares_owned_after":337644.0,"shares_owned_after_display":"337,644","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-19","filed_date":"2017-05-24","scope":"insider"},{"id":5117637,"accession":"0001104659-17-033512","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-033512","line_url":"/filing/0001104659-17-033512#line-1","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":361.0,"shares_display":"361","price_per_share":8.95,"price_display":"8.95","price_state":"stated","total_value":3230.95,"total_display":"3,230.95","total_whole":"3,231","shares_owned_after":242433.0,"shares_owned_after_display":"242,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-15","filed_date":"2017-05-17","scope":"insider"},{"id":4559818,"accession":"0000886163-17-000057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-17-000057","line_url":"/filing/0000886163-17-000057#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14582.0,"shares_display":"14,582","price_per_share":111.8731,"price_display":"111.87","price_state":"stated","total_value":1631333.5442,"total_display":"1,631,333.54","total_whole":"1,631,334","shares_owned_after":116651.0,"shares_owned_after_display":"116,651","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-12","filed_date":"2017-05-12","scope":"insider"},{"id":4559813,"accession":"0000886163-17-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-17-000057","line_url":"/filing/0000886163-17-000057#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22665.0,"shares_display":"22,665","price_per_share":110.0386,"price_display":"110.04","price_state":"stated","total_value":2494024.869,"total_display":"2,494,024.87","total_whole":"2,494,025","shares_owned_after":131233.0,"shares_owned_after_display":"131,233","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-11","filed_date":"2017-05-12","scope":"insider"},{"id":5337971,"accession":"0000886163-17-000033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-17-000033","line_url":"/filing/0000886163-17-000033#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":107.58,"price_display":"107.58","price_state":"stated","total_value":753060.0,"total_display":"753,060.00","total_whole":"753,060","shares_owned_after":153898.0,"shares_owned_after_display":"153,898","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-02-28","scope":"insider"},{"id":5337967,"accession":"0000886163-17-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-17-000033","line_url":"/filing/0000886163-17-000033#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":106.0,"price_display":"106.00","price_state":"stated","total_value":2650000.0,"total_display":"2,650,000.00","total_whole":"2,650,000","shares_owned_after":160898.0,"shares_owned_after_display":"160,898","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-27","filed_date":"2017-02-28","scope":"insider"},{"id":2229591,"accession":"0000886163-16-000249","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-16-000249","line_url":"/filing/0000886163-16-000249#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3478.0,"shares_display":"3,478","price_per_share":106.96,"price_display":"106.96","price_state":"stated","total_value":372006.88,"total_display":"372,006.88","total_whole":"372,007","shares_owned_after":185898.0,"shares_owned_after_display":"185,898","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-25","filed_date":"2016-11-25","scope":"insider"},{"id":2229584,"accession":"0000886163-16-000249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-16-000249","line_url":"/filing/0000886163-16-000249#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15001.0,"shares_display":"15,001","price_per_share":107.3972,"price_display":"107.40","price_state":"stated","total_value":1611065.3972,"total_display":"1,611,065.40","total_whole":"1,611,065","shares_owned_after":189376.0,"shares_owned_after_display":"189,376","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-22","filed_date":"2016-11-25","scope":"insider"},{"id":2765303,"accession":"0000886163-16-000247","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-16-000247","line_url":"/filing/0000886163-16-000247#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":105.0,"price_display":"105.00","price_state":"stated","total_value":525000.0,"total_display":"525,000.00","total_whole":"525,000","shares_owned_after":204377.0,"shares_owned_after_display":"204,377","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-18","filed_date":"2016-11-18","scope":"insider"},{"id":2765293,"accession":"0000886163-16-000247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-16-000247","line_url":"/filing/0000886163-16-000247#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1330.0,"shares_display":"1,330","price_per_share":106.33,"price_display":"106.33","price_state":"stated","total_value":141418.9,"total_display":"141,418.90","total_whole":"141,419","shares_owned_after":209377.0,"shares_owned_after_display":"209,377","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-16","filed_date":"2016-11-18","scope":"insider"},{"id":5313955,"accession":"0001104659-17-025903","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-025903","line_url":"/filing/0001104659-17-025903#line-1","is_derivative":false,"issuer_cik":"0001376960","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001376960","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":295929.0,"shares_display":"295,929","price_per_share":5.855,"price_display":"5.86","price_state":"stated","total_value":1732664.295,"total_display":"1,732,664.30","total_whole":"1,732,664","shares_owned_after":343216.0,"shares_owned_after_display":"343,216","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-16","filed_date":"2017-04-25","scope":"insider"},{"id":3273461,"accession":"0000886163-16-000174","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-16-000174","line_url":"/filing/0000886163-16-000174#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":118.5222,"price_display":"118.52","price_state":"stated","total_value":1777833.0,"total_display":"1,777,833.00","total_whole":"1,777,833","shares_owned_after":210707.0,"shares_owned_after_display":"210,707","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-06","filed_date":"2016-05-09","scope":"insider"},{"id":3273458,"accession":"0000886163-16-000174","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-16-000174","line_url":"/filing/0000886163-16-000174#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":120.2121,"price_display":"120.21","price_state":"stated","total_value":1202121.0,"total_display":"1,202,121.00","total_whole":"1,202,121","shares_owned_after":225707.0,"shares_owned_after_display":"225,707","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-05","filed_date":"2016-05-09","scope":"insider"},{"id":2122074,"accession":"0000886163-16-000156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-16-000156","line_url":"/filing/0000886163-16-000156#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":102.49,"price_display":"102.49","price_state":"stated","total_value":51245.0,"total_display":"51,245.00","total_whole":"51,245","shares_owned_after":235707.0,"shares_owned_after_display":"235,707","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-08","filed_date":"2016-03-09","scope":"insider"},{"id":2122069,"accession":"0000886163-16-000156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-16-000156","line_url":"/filing/0000886163-16-000156#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5629.0,"shares_display":"5,629","price_per_share":101.065,"price_display":"101.06","price_state":"stated","total_value":568894.885,"total_display":"568,894.88","total_whole":"568,895","shares_owned_after":236207.0,"shares_owned_after_display":"236,207","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-07","filed_date":"2016-03-09","scope":"insider"},{"id":8821867,"accession":"0001140361-15-045998","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-045998","line_url":"/filing/0001140361-15-045998","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"QLT INC/BC","issuer_ticker":"QLTI","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":"0001376960","owner_name":"Aryeh Jason","owner_display_name":"Aryeh Jason","owner_url":"/insider/0001376960","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18400.0,"shares_display":"18,400","price_per_share":2.4997826086956523,"price_display":"2.50","price_state":"stated","total_value":45996.0,"total_display":"45,996.00","total_whole":"45,996","shares_owned_after":461078.0,"shares_owned_after_display":"461,078","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-29","filed_date":"2015-12-30","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2015-12-29|8821865","ledger_fault":false,"count":{"value":204,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":88,"open_market":true},{"code":"S","label":"Open-market sale","n":116,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":204},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000886163","name":"LIGAND PHARMACEUTICALS INC","url":"/issuer/0000886163","role":"Director","n_filings":39,"first_seen":"2007-06-01","last_seen":"2026-06-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001814114","name":"Orchestra BioMed Holdings, Inc.","url":"/issuer/0001814114","role":"Director","n_filings":3,"first_seen":"2025-09-19","last_seen":"2026-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001274792","name":"MERRIMACK PHARMACEUTICALS INC","url":"/issuer/0001274792","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2019-07-15","last_seen":"2019-07-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001660719","name":"Aralez Pharmaceuticals Inc.","url":"/issuer/0001660719","role":"Director","n_filings":2,"first_seen":"2017-04-25","last_seen":"2017-05-24"},{"type":"issuer","type_label":"ISSUER","cik":"0000827809","name":"NOVELION THERAPEUTICS INC.","url":"/issuer/0000827809","role":"Director","n_filings":3,"first_seen":"2015-06-18","last_seen":"2017-05-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001459450","name":"Myrexis, Inc.","url":"/issuer/0001459450","role":"Director","n_filings":13,"first_seen":"2011-11-15","last_seen":"2012-06-20"},{"type":"issuer","type_label":"ISSUER","cik":"0000072444","name":"NABI BIOPHARMACEUTICALS","url":"/issuer/0000072444","role":"Director","n_filings":33,"first_seen":"2009-11-18","last_seen":"2011-03-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001376960","retrieved_at":"2026-08-23T07:32:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}